MALT lymphoma CT: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) |
Ahmed Younes (talk | contribs) No edit summary |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{SR}}, {{AY}} | ||
==Overview== | ==Overview== | ||
If the disease is limited to the stomach (which is assessed with [[computed tomography]]), then 70-80% of patients will have a complete regression on treatment with [[antibiotic]] eradication of ''H. pylori''. <ref>{{cite journal | author = Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M | title = Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. | journal = Lancet | volume = 345 | issue = 8965 | pages = 1591-4 | year = 1995 | id = PMID 7783535}}</ref> | Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.<ref name="pmid23879202">{{cite journal| author=Nasser QJ, Pfeiffer ML, Romaguera J, Fowler N, Debnam JM, Samaniego F et al.| title=Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma. | journal=Leuk Lymphoma | year= 2014 | volume= 55 | issue= 5 | pages= 1013-7 | pmid=23879202 | doi=10.3109/10428194.2013.826353 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23879202 }} </ref> If the disease is limited to the stomach (which is assessed with [[computed tomography]]), then 70-80% of patients will have a complete regression on treatment with [[antibiotic]] eradication of ''H. pylori''.<ref name=vujhg>{{cite journal | author = Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M | title = Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. | journal = Lancet | volume = 345 | issue = 8965 | pages = 1591-4 | year = 1995 | id = PMID 7783535}}</ref> | ||
==CT== | |||
Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.<ref name="pmid23879202">{{cite journal| author=Nasser QJ, Pfeiffer ML, Romaguera J, Fowler N, Debnam JM, Samaniego F et al.| title=Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma. | journal=Leuk Lymphoma | year= 2014 | volume= 55 | issue= 5 | pages= 1013-7 | pmid=23879202 | doi=10.3109/10428194.2013.826353 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23879202 }} </ref> If the disease is limited to the stomach (which is assessed with [[computed tomography]]), then 70-80% of patients will have a complete regression on treatment with [[antibiotic]] eradication of ''H. pylori''.<ref name=vujhg>{{cite journal | author = Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M | title = Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. | journal = Lancet | volume = 345 | issue = 8965 | pages = 1591-4 | year = 1995 | id = PMID 7783535}}</ref> | |||
==References== | ==References== | ||
| Line 10: | Line 14: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 19:08, 18 December 2017
|
MALT lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
MALT lymphoma CT On the Web |
|
American Roentgen Ray Society Images of MALT lymphoma CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]
Overview
Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.[1] If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori.[2]
CT
Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.[1] If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori.[2]
References
- ↑ 1.0 1.1 Nasser QJ, Pfeiffer ML, Romaguera J, Fowler N, Debnam JM, Samaniego F; et al. (2014). "Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma". Leuk Lymphoma. 55 (5): 1013–7. doi:10.3109/10428194.2013.826353. PMID 23879202.
- ↑ 2.0 2.1 Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995). "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group". Lancet. 345 (8965): 1591–4. PMID 7783535.